Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies and is not a clinically homogeneous disease, but subsets of patients with distinct prognosis and response to therapy can be identified by genome-wide analyses. | High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma